Your Advocates Ltd. LLP reduced its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 49.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 150 shares of the healthcare conglomerate’s stock after selling 148 shares during the period. Your Advocates Ltd. LLP’s holdings in UnitedHealth Group were worth $76,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also made changes to their positions in UNH. Accredited Investors Inc. boosted its holdings in shares of UnitedHealth Group by 9,235.4% in the third quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate’s stock valued at $458,929,000 after acquiring an additional 776,516 shares in the last quarter. Caisse DE Depot ET Placement DU Quebec boosted its holdings in shares of UnitedHealth Group by 129.7% in the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,029,540 shares of the healthcare conglomerate’s stock valued at $601,951,000 after acquiring an additional 581,324 shares in the last quarter. State Street Corp boosted its holdings in shares of UnitedHealth Group by 1.3% in the third quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock valued at $26,626,387,000 after acquiring an additional 563,554 shares in the last quarter. B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in shares of UnitedHealth Group in the third quarter valued at about $276,785,000. Finally, Canoe Financial LP acquired a new stake in shares of UnitedHealth Group in the third quarter valued at about $216,166,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.
Insiders Place Their Bets
In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The stock was bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 0.33% of the stock is currently owned by insiders.
Wall Street Analysts Forecast Growth
Check Out Our Latest Stock Report on UNH
UnitedHealth Group Stock Performance
NYSE:UNH opened at $465.58 on Friday. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The firm has a 50 day simple moving average of $519.27 and a 200-day simple moving average of $560.48. The firm has a market cap of $428.46 billion, a PE ratio of 30.04, a P/E/G ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group’s revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the firm posted $5.83 earnings per share. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
- Five stocks we like better than UnitedHealth Group
- How to Most Effectively Use the MarketBeat Earnings Screener
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- DuPont’s Electronics Spinoff: The Start of Something Big
- Buy P&G Now, Before It Sets A New All-Time High
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.